contadores web
Skip to main navigation menu Skip to main content Skip to site footer

Quality of health services

Vol. 27 No. 2 (2025)

Timelines associated with the neonatal jaundice care cycle and assessment of caregiver satisfaction

DOI
https://doi.org/10.22267/rus.252702.345
Submitted
March 18, 2024
Published
2025-05-01

Abstract

Introduction: Neonatal hyperbilirubinemia is a major health problem, a common cause of morbidity. Worldwide, it affects up to 60% of term newborns. Its diagnosis is by means of serum bilirubin levels, which is associated with certain disadvantages, especially in terms of discomfort related to delayed results. Objective: To evaluate the relationship between caregiver satisfaction and the time associated with the cycle of care for the diagnosis of neonatal jaundice. Materials and methods: Cross-sectional observational study, neonates with clinical evidence of jaundice were included. Demographic data were collected, a satisfaction survey was applied to evaluate the level of caregiver satisfaction, and the times associated with the cycle of care from the moment of admission to the medical procedure were recorded. Results: A patient flow analysis was performed, and it was found that waiting time is significant, especially in obtaining laboratory results. Caregivers' satisfaction with waiting times influences their overall perception of service quality. Conclusions: The potential implementation of new diagnostic instruments could generate added value to the service by speeding up medical decision making.

References

  1. Bhutani VK, Johnson LH. Jaundice and hyperbilirubinemia in the newborn. In: Kliegman R, St. Geme III JW eds. Nelson Textbook of Pediatrics. 21st ed. Elsevier; 2019:858-869. Available from: https://shop.elsevier.com/books/nelson-textbook-of-pediatrics-2-volume-set/kliegman/978-0-323-52950-1
  2. Guamán-Noboa JM, Yauli-Flores CF. Neonatal hyperbilirubinemia and the role of the clinical laboratory in diagnosis. Med Lab [Internet]. 2023; 27(4):369-381. Available from: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=112881&idP=10455
  3. Martínez LI. Ictericia neonatal - hiperbilirrubinemia indirecta. Soc Colomb Pediatr [Internet]. 2011; 2:38–55. Available from: http://www.neopuertomontt.com/USS/Pasada_Neonatologia/Modulos_Neonatologia/Modulo_Gastroenterologia /Ictericia_neonatal.pdf
  4. Hospital de San José. Informe de la Oficina de Estadística y Epidemiología del Hospital de San José. 2019. Available from: https://hospitaldesanjose.org.co/wp-content/uploads/2024/04/IG2023-SociedaddeCirugíadeBogotá_HospitaldeSanJosé%20%281%29.pdf
  5. Salazar-Porras D, Aguilar-Hernández LM, González-Alfaro FJ. Neonatal jaundice: frequent clinical manifestation in pediatrics. Rev Med Sinerg [Internet]. 2023; 8(8):e1085. DOI: 10.31434/rms.v8i8.1085
  6. Campbell-Wagemann S, Mena-Nannig P. Severe hyperbilirubinemia in newborns, risk factors and neurological outcomes. Rev Chil Pediatr [Internet]. 2019; 90(3):267-274. DOI: 10.32641/rchped.v90i3.772
  7. Hulzebos CV, Vitek L, Coda-Zabetta CD, Dvořák A, Schenk P, Van der Hagen EAE. et al. Diagnostic methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments. Pediatr Res [Internet]. 2021; 90(2):277–283. DOI: 10.1038/s41390-021-01546-y
  8. Perdomo-Rodríguez AP, Urriago-Campos PA, Castro Ramirez WG. Most frequent complications related to a peripheral venipuncture. CINA Res [Internet]. 2019; 3(3):41-45. Available from: https://journals.uninavarra.edu.co/index.php/cinaresearch/article/view/187
  9. Ngashangva L, Bachu V, Goswami P. Development of new methods for determination of bilirubin. J Pharm Biomed Anal [Internet]. 2019; 162:272-285. DOI: 10.1016/j.jpba.2018.09.034
  10. Ramachandran A, Owen L, Morris R. Un proyecto comunitario sobre ictericia. Niño. 2016; 12(4):125–129. DOI: 10.1136/archdischild-2015-308599.110
  11. Hernández-Ávila CE, Carpio N. Introducción a los tipos de muestreo. Alerta [Internet]. 2019; 2(1):75-79. Available from: https://alerta.salud.gob.sv/introduccion-a-los-tipos-de-muestreo
  12. Souza DL, Korzenowski AL, Alvarado MM, Sperafico JH, Ackermann AEF, Mareth T, et al. A systematic review on lean applications’ in emergency departments. Healthcare (Basel) [Internet]. 2021; 9(6):763. DOI: 10.3390/healthcare9060763
  13. Haron SHA, Ramlan R. Patient Process Flow Improvement: Value Stream Mapping. J Manag Res. 2015;7(2). DOI: 10.5296/jmr.v7i2.6988
  14. Marin-Garcia JA, Vidal-Carreras PI, Garcia-Sabater JJ. The role of value stream mapping in healthcare services: A scoping review. Int J Environ Res Public Health [Internet]. 2021; 18(3):951. DOI: 10.3390/ijerph18030951
  15. Le DX, Do HT, Bui KT, Hoang TQ, Nguyen GH, Nguyen AV, et al. Lean management for improving hospital waiting times—Case study of a Vietnamese public/general hospital emergency department. Int J Health Plann Manage [Internet]. 2022; 37(1):159-170. DOI: 10.1002/hpm.3310
  16. Al Muflih A, Noor-E-alam M. Integrated Lean Concept to Healthcare Delivery Framework for Urgent Care at Home. In: Proceedings of the International Conference on Industrial Engineering and Operations Management. 2021. Available from: https://ieomsociety.org/proceedings/2021haiti/210.pdf
  17. de Barros LB, Bassi LC, Caldas LP, Sarantopoulos A, Zeferino EBB, Minatogawa V, et al. Lean healthcare tools for processes evaluation: An integrative review. Int J Environ Res Public Health [Internet]. 2021; 18(14):7389. DOI: 10.3390/ijerph18147389
  18. Kaushik N, Khangulov VS, O'Hara M, Arnaout R. Reduction in laboratory turnaround time decreases emergency room length of stay. Open Access Emerg Med. 2018; 10:37-45. DOI: 10.2147/OAEM.S155988
  19. McClean S, Baerg K, Smith-Fehr J, Szafron M. Cost savings with transcutaneous screening versus total serum bilirubin measurement for newborn jaundice in hospital and community settings: a cost-minimization analysis. CMAJ Open [Internet]. 2018; 6(3):e285-e291
  20. Boudreaux ED, O'Hea EL. Patient satisfaction in the Emergency Department: a review of the literature and implications for practice. J Emerg Med [Internet]. 2004; 26(1):13-26. DOI: 10.1016/j.jemermed.2003.04.003
  21. Health Committee. The Use of New Medical Technologies within the NHS Fifth Report of Session 2004–05. London (GBR): House of Commons; 2005. Available from: https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/398/398ii.pdf
  22. Rathore M, Jackson M, Committee on Infectious Diseases, Byington CL, Maldonado YA, Barnett ED, et al. Infection Prevention and Control in Pediatric Ambulatory Settings. Pediatrics [Internet]. 2017; 140(5):e20172857. DOI: 10.1542/peds.2017-2857
  23. Bhatt DR, Henry AIK, Sunjeeve CL, David W, Bhutani VK, Maisels MJ, et al. Transcutaneous bilirubinometer use and practices surrounding jaundice in 150 California newborn intensive care units. J Perinatol [Internet]. 2018; 38(11):1532-1535. DOI: 10.1038/s41372-018-0154-3
  24. Chua BS, Song LH, Chang CT, Lim XJ, Nachiappan J. Drive-through transcutaneous bilirubin screening for neonatal jaundice: A safe and efficient system during the COVID-19 pandemic. J Paediatr Child Health [Internet]. 2021; 57(1):12–14. DOI: 10.1111/jpc.15226
  25. van den Esker-Jonker B, den Boer L, Pepping RMC, Bekhof J. Transcutaneous bilirubinometry in jaundiced neonates: A randomized controlled trial. Pediatrics [Internet]. 2016; 138(6):e20162414.
  26. Rylance S, Yan J, Molyneux E. Can transcutaneous bilirubinometry safely guide phototherapy treatment of neonatal jaundice in Malawi? Paediatr Int Child Health [Internet]. 2014; 34(2):101–107. DOI: 10.1179/2046905513Y.0000000050
  27. Johnson SM, Vasu V, Marseille C, Hill C, Janvier L, Toussaint P, et al. Validation of transcutaneous bilirubinometry during phototherapy for detection and monitoring of neonatal jaundice in a low-income setting. Paediatr Int Child Health [Internet]. 2020; 40(1):25–29. DOI: 10.1080/20469047.2019.1598126

Downloads

Download data is not yet available.